These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 23225456

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Allard MA, Sebagh M, Baillie G, Lemoine A, Dartigues P, Faitot F, Faron M, Boige V, Vitadello F, Vibert E, Elias D, Adam R, Goéré D, Sa Cunha A.
    Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
    [Abstract] [Full Text] [Related]

  • 23. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 24. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 25. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [Abstract] [Full Text] [Related]

  • 26. Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.
    Lim A, Le Sourd S, Senellart H, Luet D, Douane F, Perret C, Bouvier A, Métairie S, Cauchin E, Rougier P, Matysiak-Budnik T, Touchefeu Y.
    Clin Colorectal Cancer; 2017 Dec; 16(4):308-315. PubMed ID: 28433600
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases.
    White RR, Schwartz LH, Munoz JA, Raggio G, Jarnagin WR, Fong Y, D'Angelica MI, Kemeny NE.
    J Surg Oncol; 2008 Jun 01; 97(7):601-4. PubMed ID: 18449915
    [Abstract] [Full Text] [Related]

  • 34. Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
    Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F, ARTBC International.
    Eur J Cancer; 2016 Nov 01; 68():163-172. PubMed ID: 27768923
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B, Van Nieuwenhove Y, Aerts M, Fontaine C, Vermeij J, Schallier D, Decoster L, De Mey J, Vandenbroucke F, Hoorens A, Delvaux G, De Gréve J.
    Anticancer Res; 2006 Nov 01; 26(1B):611-9. PubMed ID: 16739329
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 38. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
    Fujimoto T, Yoshimatsu K, Yokomizo H, Umehara A, Watanabe K, Ohtani T, Matsumoto A, Ohsawa G, Ishibashi K, Ogawa K.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(12):1838-40. PubMed ID: 17212122
    [Abstract] [Full Text] [Related]

  • 39. Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
    Pasetto LM, Merenda R, Pilati P, Sinigaglia G, Monfardini S.
    Anticancer Res; 2006 Nov 01; 26(6C):4785-92. PubMed ID: 17214342
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.